3.48
0.20 (6.10%)
| Penutupan Terdahulu | 3.28 |
| Buka | 3.27 |
| Jumlah Dagangan | 43,142 |
| Purata Dagangan (3B) | 584,416 |
| Modal Pasaran | 7,257,063 |
| Harga / Buku (P/B) | 2.22 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Nov 2025 |
| EPS Cair (TTM) | -0.700 |
| Nisbah Semasa (MRQ) | 1.93 |
| Aliran Tunai Operasi (OCF TTM) | -9.37 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -4.87 M |
| Pulangan Atas Aset (ROA TTM) | -106.68% |
| Pulangan Atas Ekuiti (ROE TTM) | -285.79% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Acurx Pharmaceuticals, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Purata | 1.00 |
|
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company’s segment consists of the development of clinical and preclinical product candidates for the development of the Company’s proprietary new therapies. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 10.95% |
| % Dimiliki oleh Institusi | 18.21% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Prospect Financial Services Llc | 30 Sep 2025 | 19,883 |
| Nbc Securities, Inc. | 30 Sep 2025 | 1,500 |
| Gps Wealth Strategies Group, Llc | 30 Sep 2025 | 1,225 |
| Cornerstone Planning Group Llc | 30 Sep 2025 | 67 |
| Julat 52 Minggu | ||
| Median | 31.00 (790.81%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 30 Sep 2025 | 31.00 (790.80%) | Beli | 4.29 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |